Skip to content

Latest

Yaral Pharma partners with EVERSANA

Yaral Pharma partners with EVERSANA

Yaral Pharma the United States generics subsidiary of IBSA (Institut Biochimique SA) announced its expanding partnership with EVERSANA, a leading provider of commercialization services to the global life sciences industry, as its key commercialization partner to support the expansion of its portfoli

FDA approves the Cyltezo Pen

FDA approves the Cyltezo Pen

RIDGEFIELD, Conn. – Boehringer Ingelheim announced Monday that the U.S. Food and Drug Administration (FDA) has approved the Cyltezo Pen, a new autoinjector option for Cyltezo (adalimumab-adbm), an FDA-approved Interchangeable biosimilar to Humira (adalimumab).

Circana launches Passport+

Circana launches Passport+

 CHICAGO – Circana, formerly IRI and The NPD Group, today announced the launch of Passport+, unleashing outsize growth for small to midsize CPG companies through comprehensive data, insight, and reporting solutions.

Walmart reports strong Q1 results

Walmart reports strong Q1 results

BENTONVILLE, Ark. – Walmart said Thursday that revenue increased 7.6% to $152.3 billion in its first quarter, topping Wall Street expectations. The company also raised its fiscal 2024 forecast; management now expects consolidated net sales will rise about 3.5% this year.